← All organizations

Helen Keller International

Academic/HospitalWebsite ↗

Also known as: Helen Keller International

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Apr 20, 2024

Timeline

1910s

Jan 1, 1915
Helen Keller International— Founded

Drugs by trial phase (14 distinct, 14 trials)

Phase 4 (5 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

thiamine

Other trials (8 own, 0 via acquisition)

Indications

Studied for

Recent trials (18)

NCT06327646Lead sponsorN/AApr 20, 2024
NCT06327646OfficialN/AApr 20, 2024
NCT06327646Sponsor investigatorN/AApr 20, 2024
NCT05177614CollaboratorN/ANov 23, 2021
NCT04716712CollaboratorPhase 4Oct 4, 2021
NCT04224987CollaboratorPhase 4Sep 30, 2020
NCT04017598CollaboratorPhase 4Jul 31, 2019
NCT03616288CollaboratorN/ASep 30, 2018
NCT02481375CollaboratorN/AJul 31, 2015
NCT02221063CollaboratorPhase 1Oct 31, 2014
NCT02221063Study chairPhase 1Oct 31, 2014
NCT01803659CollaboratorN/AJan 1, 2013
NCT00944359CollaboratorPhase 4Dec 1, 2010
NCT01015950Lead sponsorN/AMay 1, 2010
NCT01015950Overall official - principal investigatorN/AMay 1, 2010

Details

Founded: New York, NY, US Jan 1, 1915
Last known activity: Apr 20, 2024